Infect Immun 2009, 77:232–244 PubMedCrossRef 40 Norcia LJ, Silvi

Infect Immun 2009, 77:232–244.PubMedCrossRef 40. Norcia LJ, Silvia AM, Santoro SL, Retsema

J, Letavic MA, Bronk BS, Lundy KM, Yang B, Evans NA, Hayashi SF: In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory Stem Cell Compound Library cell line pathogens. J Antibiot (Tokyo) 2004, 57:280–288. 41. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM: In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci USA 2007, 104:6037–6042.PubMedCrossRef 42. Raynaud C, Meibom KL, Lety MA, Dubail I, Candela T, Frapy E, Charbit A: Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity.

Infect Immun 2007, 75:536–541.PubMedCrossRef 43. Cowley SC, Gray CJ, Nano FE: Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis. FEMS Microbiol Lett 2000, 182:63–67.PubMedCrossRef 44. Shapiro DS, Schwartz DR: Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure. J Clin Microbiol 2002, 40:2278–2281.PubMedCrossRef 45. Hassoun A, Spera R, Dunkel J: Tularemia and once-daily gentamicin. Antimicrob Agents Chemother 2006, 50:824.PubMedCrossRef 46. Harrell RE Jr, Simmons HF: Pleuropulmonary tularemia: successful treatment with erythromycin. South Med J 1990, 83:1363–1364.PubMedCrossRef Protease Inhibitor Library 47. Westerman EL, McDonald J: Tularemia pneumonia mimicking legionnaires’ disease: isolation of organism on CYE agar and successful treatment with erythromycin. South Med J 1983, 76:1169–1170.PubMedCrossRef 48. Mizunoe S, Kadota J, Tokimatsu I, Kishi K, Nagai H, Nasu M: Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation Amisulpride of Bcl-xL. Int Immunopharmacol 2004, 4:1201–1207.PubMedCrossRef 49. Platz GJ,

Bublitz DC, Mena P, Benach JL, Furie MB, Thanassi DG: A tolC Mutant of Francisella tularensis Is Hypercytotoxic Compared to the Wild Type and Elicits Increased Proinflammatory Responses from Host Cells. Infect Immun 78:1022–1031. 50. Hoyt JC, Robbins RA: Macrolide antibiotics and pulmonary inflammation. FEMS Microbiol Lett 2001, 205:1–7.PubMedCrossRef 51. Fietta AM, Meloni F: Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome. Curr Med Chem 2008, 15:716–723.PubMedCrossRef 52. Johansson A, Berglund L, Gothefors L, Sjostedt A, Tarnvik A: Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J 2000, 19:449–453.PubMedCrossRef 53. Zimpfer A, Propst A, Mikuz G, Vogel W, Terracciano L, Stadlmann S: Ciprofloxacin-induced acute liver injury: case report and review of literature. Virchows Arch 2004, 444:87–89.PubMedCrossRef 54. Dichiara AJ, Atkinson M, Goodman Z, Sherman KE: Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review.

Comments are closed.